Andy Molnar is the CEO of the Digital Therapeutics Alliance (DTA), a trade organization focused on the needs of the clinically validated digital therapeutics industry. Before joining DTA, Andy worked in leadership roles with industry companies Cognoa and Pear Therapeutics, focusing on how to commercialize software as a medical device (SaMD) products, generating meaningful evidence for payors, commercial planning, and working with various government agencies and trade organizations to update policy for reimbursement.

© 2024 BioFutureTM. All Rights Reserved

Produced by